Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Protein degrader specialist Lycia prices $318M IPO

Funds from the upsized offering will support a trio of protein-degrading medicines in development for allergic conditions as well as the autoimmune disorder Graves’ disease.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Finance & Markets

Japanese Market Sharply Lower

(RTTNews) - The Japanese market is trading sharply lower on Friday, extending the losses in the previous session, following the mixed cues from Wall Street overnight.

More from Friday 23 October →